Metabolic and gut microbiome responses to personalized nutrition during metformin therapy in prediabetes and early‑stage type 2 diabetes: a randomized clinical trial

Zehra I. Uluturk, Anastasia Godneva, Sienna Walsh, Mallory Ledger, Eliza Chalmers, Jennifer R. Snaith, Tien-Ming Hng, Renee Richens, Krisztina Toth, Jennifer Evans, Jian Tan, Laurence Macia, Mark Danta, Eran Elinav, Eran Segal, Jerry R. Greenfield, Dorit Samocha-Bonet
Communications Medicine · Springer Nature · 2026-11-19 · DOI: 10.1038/s43856-026-02009-3

Аннотация

Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication for people with type 2 diabetes, but it does not always improve blood sugar levels. This study tests whether diet guidance, based on an individual’s data, could reduce blood sugar spikes after meals more than following a standard healthy diet. In this study, people starting metformin followed either a personalized diet or a standard low fat, high-fiber diet for six months. Both groups showed similar improvements in blood sugar, body weight, and health markers.

Читать у издателя →

Похожие статьи